EMPIRE CONSULTING GROUP

Lobbying for GILEAD SCIENCES INC. · Biopharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 18, 2026

Lobbying activity 1

Health Issues

Issues related to health access. Issues related to HIV medication.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem